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Background: Numerous studies highlight an important gap in the quality of care for depression in primary care.
However, basic indicators were often used. Few of these studies examined factors associated with receiving
adequate treatment, particularly with a simultaneous consideration of individual and organizational characteristics.
The purpose of this study was to estimate the proportion of primary care patients with a major depressive episode
(MDE) who receive adequate treatment and to examine the individual and organizational (i.e., clinic-level)
characteristics associated with the receipt of at least one minimally adequate treatment for depression.
Methods: The sample used for this study included 915 adults consulting a general practitioner (GP), regardless of
the motive of consultation, meeting DSM-IV criteria for MDE during the 12 months preceding the survey (T1), and
nested within 65 primary care clinics. Data reported in this study were obtained from the “Dialogue” project.
Adherence rates for 27 quality indicators selected to cover the most important components of depression
treatment were estimated. Multilevel analyses were conducted.
Results: Adherence to guidelines was high (>75%) for one third of the quality indicators that were measured but
was low (<60%) for nearly half of the measures. Just over half of the sample (52.2%) received at least one minimally
adequate treatment for depression. At the individual level, determinants of receipt of minimally adequate care
included age, having a family physician, a supplementary insurance coverage, a comorbid anxiety disorder and the
severity of depression. At the clinic level, determinants included the availability of psychotherapy on-site, the use of
treatment algorithms, and the mode of remuneration.
Conclusions: Our findings suggest that interventions are needed to increase the extent to which primary mental
health care conforms to evidence-based recommendations. These interventions should target specific populations
(i.e. the younger adults and the elderly), enhance accessibility to psychotherapy and to a regular family physician,
and support primary care physicians in their clinical practice with patients suffering from depression in different
ways such as developing knowledge to treat depression and adapting mode of remuneration.
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Major depressive episode (MDE) is a very common dis-
order with a lifetime prevalence estimated at 12.2% [1].
MDE is the leading cause of disease burden in developed
nations in terms of years lived with disability [2]. Indivi-
duals with depression also commonly experience multiple* Correspondence: arnaud.duhoux@umontreal.ca
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reproduction in any medium, provided the orepisodes of relapse and recurrence leading depression to
be viewed as a chronic condition [3].
The critical role of primary care in the detection and
treatment of depression is now widely recognized [4].
Unfortunately, numerous studies highlight an important
gap in depression treatment in primary care settings,
where this disorder is often not treated or not ad-
equately treated [5-7]. However, other studies suggest
that when primary care for depression is minimally con-
sistent with clinical practice guidelines patients experi-
ence fewer symptoms [8-11], improved quality of life
[8,9] and functioning [12], and have a reduced risk ofl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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mary care is also associated with increased treatment
cost-effectiveness [15].
Since the 1990s, a number of countries have developed
evidence-based clinical practice guidelines in an effort to
improve the quality of care for depression [16-21]. These
guidelines have been developed on the basis of clinical re-
search syntheses and expert consensus reports. Optimal
strategies for treating depression have been described, in
both psychiatric and primary care settings. The two main
recognized treatment options for depression are pharma-
cotherapy and psychotherapy [19].
Clinical practice guidelines are also increasingly used
to establish standards for treatment quality at a popula-
tion level. Quality indicators measure the gap between
actual care received by patients and established stan-
dards. They provide tools for evaluating processes of
care (technical and interpersonal aspects of care deliv-
ered to patients) [22,23] according to Donabedian’s triad
of structure, process, and outcome to conceptualize the
quality of health care [24]. Many authors have under-
scored the importance of using process indicators for
measuring the quality of care [22,23,25-27]. Measure-
ment of quality at the population level cannot address
the specificities of each individual or situational peculiar-
ities in which deviating from practice guidelines might
be appropriate. Quality indicators must therefore be
considered minimal standards of care.
Given the increased interest in the quality of care for
mental health problems in the previous decade, there
has been a proliferation of measurement indicators [28].
However, no consensus has emerged regarding the most
appropriate indicators of quality for the treatment of de-
pression in primary care and few indicators have been
subjected to validation efforts [7,28].
One of the main findings of a systematic review of lit-
erature on quality indicators for treatment of depression
in primary care that we published recently [28] was that
most of the studies reviewed used only rudimentary
indicators to measure the quality of treatment for de-
pression. This gap was particularly evident in studies
assessing the quality of psychotherapy. For example, the
majority of studies used a minimum number of visits as
an indicator for psychotherapy quality without details on
the duration of visits or the type of psychotherapy used.
We also noted that the vast majority of studies on qual-
ity of treatment for depression did evaluate the quality
of pharmacotherapy. However, the accuracy of indicators
was uneven. Some details such as number of prescrip-
tions, dosage of antidepressants (ATD), and number of
follow-up visits were not always assessed. One conse-
quence of relying on quality measures that are too basic
is that important aspects of depression care are left
unassessed, providing an incomplete picture of the caredepressed individuals receive. In this review, we recom-
mended the development and use of more sophisticated
indicators of quality.
Quality indicators that combine elements of both
pharmacotherapy and psychotherapy encompass both of
the main treatment options and provide a potentially
more accurate assessment of depression treatment quality.
A number of studies have used indicators that account for
the quality of pharmacotherapy and/or the quality of psy-
chotherapy by creating a global quality indicator that mea-
sures minimal treatment adequacy [28]. The prevalence
rates ranged from 14% to 56% suggesting that a large pro-
portion of people suffering from depression do not receive
minimally adequate treatment. Studies including indica-
tors related to patient education about depression also
showed large disparities with adequacy rates ranging from
23% to 100%.
Few of these studies examined the various factors
associated with receiving adequate treatment, and the
results obtained in this regard were conflicting. Ander-
sen’s Behavioral Model of Health Care [29] is a well-
known model, developed for utilization of care studies.
It has been used in some studies related to adequacy of
treatment for depression to identify individual factors
potentially associated with adequate treatment [7,30-32].
The model considers an individual’s use of services as a
function of their predisposing characteristics, enabling
characteristics, and need for care. Even if multilevel ana-
lysis is particularly well suited to investigate both
patient- and clinic-level factors influencing quality of de-
pression treatment in primary care, few studies used this
analysis method in this context. Furthermore, they con-
sidered only clinician burden at the clinic level [33] or
did not focus on depressive disorder only [32,34].
The objectives of this study are therefore:
 to estimate the proportion of primary care patients
meeting DSM-IV criteria for major depressive
disorder who receive adequate treatment as assessed
by quality indicators derived from clinical practice
guidelines
 to examine the individual and organizational
(i.e., clinic-level) characteristics associated with the




Data reported in this study were obtained from the “Dia-
logue” project [35], a research program consisting of
three main interrelated components: 1) a contextual
study consisting of a qualitative examination of primary
mental health care services and contextual factors per-
ceived to influence the implementation of a provincial
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of the province of Québec (the LSN were selected for
their diversity of contexts: urban to remote, population
size, specialized resources availability, etc.); 2) a cross-
sectional organizational survey conducted in 76 primary
care clinics located in the 15 LSN to describe the vari-
ability in organizational models of primary care; and 3) a
client survey that examined the experience of care and
evolving mental health status among a cohort of adults
with anxiety and depressive disorders. Patients were
recruited in 67 of the 76 clinics that had participated in
the organizational survey and who accepted the recruit-
ment of participants in their waiting room. Following in-
cept into the cohort (T0), the tracking process involved
three telephone/web interviews conducted at six-month
intervals (T1, T2, and T3).
Data for the current investigation were drawn from the
organizational survey and from the waiting room inter-
view (i.e., inception into the cohort, T0) and the first tele-
phone/web interview (T1) of the client survey. The
procedures were approved by the Human Research Ethics
Committees of all regional authorities involved in the pro-
ject (Agence de santé de des services sociaux de Montréal;
Centres de santé de des services sociaux de Chicoutimi,
Sherbrooke, Gatineau, Laval, Saint Jérome, Jeanne-Mance,
Lac-Saint-Jean-Est, Pointe-De-L’ile, Bordeaux-Cartierville-
Saint-Laurent, Ste Therese-De-Blainville, Pierre Boucher,
Haut-Richelieu-Rouville, Baie des Chaleurs, La Pommer-
aie; Hospital Notre-Dame and Hospital Sacré-Coeur).
Study participants provided written informed consent.
These considerations are in keeping with the ethical prin-
ciples set out in the Declaration of Helsinki [36].
Participants
Sampling of clinics
For the organizational survey, recruitment letters and
questionnaires were sent to the 285 primary care clinics
of the 15 selected LSN. In 67 clinics, the respondent
most knowledgeable about the clinic’s organization and
functioning completed a standardized questionnaire and
allowed for the recruitment of participants in the waiting
room. The organizational questionnaire was adapted
from a previous study [37] to primary mental health
care. It consisted of fifty questions divided into five sec-
tions: resources and organizational structure, services
and practices, interorganisational collaboration, vision /
values and location of the clinic. The information was
collected from November 2007 to June 2008.
Sampling of persons within clinics
Participants were recruited between March and August
2008 in the waiting rooms of the 67 primary care med-
ical clinics (T0) during randomly chosen periods to en-
sure proper representation of every day of the weekand of different period of the day (morning, afternoon,
and evening). The recruitment flowchart appears in
Figure 1.
Eligibility for the waiting room interview (T0) French
and English speaking adults (18 years and over) seeking
care for themselves from a general practitioner (GP), re-
gardless of the motive of consultation, were approached
by trained research assistants to complete a brief self-
administered questionnaire. From the 22 600 eligible
patients approached, 67.4% (n = 14 833) completed the
questionnaire.
Eligibility for follow-up (first part of T1) Patients were
invited to participate in the first part of T1 (n = 7 522) if
their usual source of care was one of the participating
clinics and if they met at least one of the following char-
acteristics: i) high level of depressive or anxiety symp-
toms in the past week according to the Hospital Anxiety
and Depression Scale (HADS) [38] (The HADS consist
of two sub-scales; seven items measure anxiety symp-
toms (HADS-A) and seven items measure depression
symptoms (HADS-D) in the past week. Each item is
scored on a four points scale (0 to 3), with the total
score ranging from 0 to 21 for each sub-scale. A higher
score indicates major distress and a higher probability to
present an anxiety or depressive disorder. An individual
with a score of 8 or more on a sub-scale is considered to
have a possible disorder. The scale performs well to
evaluate the symptom severity of anxiety disorders and
depression in various community settings and primary
care [39] and presents good internal consistency, reli-
ability and convergeant/discriminant validity [40]); ii)
taking medication for depressive or anxiety problems
within the year previous to the survey; iii) having been
diagnosed with a depressive or anxiety disorder by a
physician; iv) consulting a health professional (GP,
psychiatrist, psychologist, etc.) for mental health reasons
within the year prior to the survey.
Among them, 4 506 (59.9%) accepted to participate to
the follow-up and provided their contact details in the
waiting room questionnaire. After 2–4 weeks, we were
able to contact by telephone and/or email 3 382 (75.1%)
individuals for a first interview (T1). A total of 2 396
(70.8%) telephone interviews and 986 (29.1%) web ques-
tionnaires were completed. The first part of the structured
interview was used to determine whether respondents had
a high probability of meeting DSM-IV criteria for an
anxiety or depressive disorder.
Eligibility for inclusion in the cohort (second part of
T1) The interview then continued with the 1 956 people
meeting any of the following criteria: i) presence of at
least one of the diagnoses assessed in the last 12 months
33 528 individuals approached in 
clinics waiting rooms
22 600 individuals eligible for 
waiting room interview
T0: waiting room interview
14 833 individuals completed 
waiting room interview
7 522 individuals eligible to follow-
up
10 928 individuals ineligible for 
waiting room interview
7 767 individuals refused or didn’t 
have enough time to complete 
waiting room interview
7311 individuals ineligible to 
follow-up
3 016 individuals refused to 
participate to follow-up or didn't 
provide contact details
4506 individuals accepted to 
participate to follow-up and 
provided their contact details
T1: first part of phone/web 
interview
3 382 individuals completed the 
CIDIS
T1: second part of phone/web 
interview
1 956 individuals included in the 
cohort survey
Final sample: 915 individuals 
meeting criteria for this study
1 124 not reached or refused at this 
step to complete follow-up
1 426 individuals not eligible for 
inclusion in the cohort survey
1041 individuals not meeting 
criteria for this study
Figure 1 Recruitment flow-chart, Dialogue Project.
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social phobia (SP) and panic disorder (PD). The CIDIS
(Composite International Diagnostic Interview Simpli-
fied) [41] was used to identify psychiatric disorders
according to the DSM-IV classification [42]); ii) a high
level of anxiety or depression symptoms combined with
medication, diagnosis by a health care professional, or
DSM-IV criteria for anxiety or depression in the past
24 months. Data collected pertained to patient health
(symptoms, disabilities, functioning, length of episode,
comorbidity), mental health care trajectory (number and
types of professionals seen, number of visits, referrals
from one professional to another, medication), accessibil-
ity of care and continuity and responsiveness of services.
Sample used for this study For the present study, the
final sample included 915 adults consulting a GP,regardless of the motive of consultation, meeting the
criteria for MDE during the 12 months preceding the
survey (T1), and nested within 65 primary care clinics
(Two clinics were excluded because we recruited only
participants with an anxiety disorder and none with
MDE).
Measures
Quality indicators for depression treatment
Quality indicators for depression treatment were estab-
lished from Canadian clinical practice guidelines [3,19]
and previous studies [7,28]. Those quality indicators were
selected to cover the most important components of de-
pression treatment and pertain to detection of depres-
sion; ATD medication prescribed, including its dosage
and follow-up; psychotherapy; information/education
received by the patient; the consideration of patient’s
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to do physical exercise to improve well-being, emotions
and mental health. Rates of adherence to 27 indicators
were evaluated with patients’ self-reported data. Each in-
dicator was considered only regarding the specific patient
population to which a care process applied. Their de-
scription appears in Table 1.
Dependent variable
Receiving at least one minimally adequate treatment
was the dichotomous dependent variable used for the
second objective and was defined as followed: minim-
ally adequate pharmacotherapy (receiving a prescription
for an ATD medication in the past 12 months plus at
least 3 medical visits) and/or minimally adequate psy-
chotherapy (12 or more consultations for mental health
reason in the previous year and at least one of the
recommended psychotherapies). The three required vis-
its for those receiving ATD medication is based on the
observation that this is the minimum necessary to
monitor effectiveness and side-effects. Similarly,
according to the Canadian recommendations, a mini-
mum of 12 visits is required for a full course of
psychotherapy.
Individual-level characteristics
Andersen’s Behavioral Model of Health Care Use [29]
was used to identify individual factors potentially asso-
ciated with adequate treatment. Predisposing factors
selected included age (18–24; 25–44; 45–64; 65+ years);
sex; educational attainment (High school or less; College;
University), and marital status (Married / Living
common-law; Widowed / separated / divorced ; Single).
Perception of economic situation (Well off / meet
basic needs - poor / very poor), having a family phys-
ician and having a supplementary insurance coverage
were selected as enabling factors.
Need for care factors included the number of co-
morbid chronic illnesses (0; 1; 2; 3 or more); suffering
from at least one co-morbid anxiety disorder (GAD,
agoraphobia, SP, PD); perceived mental health as poor or
fair; presenting a MDE in the previous 6 months, first
occurrence of depressive symptoms more than 5 years
ago and the severity of depressive symptoms, measured
as a continuous variable with the HADS.
Organizational (i.e., clinic-level) characteristics
Several types of variables can affect the adequacy of de-
pression treatment at the clinics level (level 2). We clas-
sified those variables under three categories: barriers,
resources, and practices. Among the barriers to ad-
equacy, the two variables considered were the lack of
time for follow-up and the inadequate mode of remuner-
ation to offer an “optimal level” of care for patientssuffering from anxiety or depressive disorders. Two
dummy variables were created to contrast “Not at all /
Slightly” and “Fairly” to “Highly” for multilevel analysis.
Among the resources, we examined the presence of a
case manager for patients suffering from anxiety or de-
pressive disorders which should increase the quality by
ensuring closer follow-up, the availability of psychother-
apy on-site and the type of clinic. Finally a variable on
practice was considered which should have a more dir-
ect influence on the quality: the number of GPs using
treatment algorithms with individuals suffering from
anxiety or depressive disorders, categorized as “None/
Some” – “All/Most”.
Statistical analyses
Descriptive statistics and rates of adherence to the 27
indicators were computed with PASW (Predictive Analy-
tics SoftWare) Statistics 18.0. Given the hierarchical
structure of the dataset, i.e. individuals nested within
primary care clinics, multilevel analyses were conducted
using HLM (Hierarchical Linear and Nonlinear Model-
ing) 6.07 software. The model building followed a step-
up approach as suggested by Raudenbush and Bryk [43].
The first model (or “empty” model), in which no pre-
dictor variables were specified, allowed to explore
whether or not there were variations between clinics in
likelihood of receipt of minimally adequate treatment for
depression. In the second step (model with level-1 fac-
tors), after testing for collinearity, individual correlates
were examined in the following order: predisposing fac-
tors, enabling factors, and need factors. Severity of de-
pressive symptoms, the only continuous variable, was
centered around the grand mean. Dummy variables were
created for variables with more than 2 categories.
Patient-level covariates with p-values < .1 were included
in the model. Although not reaching this criterion, sex
was included because it is customary to control for this
variable in multivariate analysis.
In the same way, clinics characteristics were examined
in the third step while adjusting for individual-level cor-
relates (final model with level-1 and level-2 factors).
Non-linear Bernoulli analyses for a dichotomous out-
come variable were used. Within clinics, samples varied
between 1 and 42 respondents. Average within clinics
sample comprised 14.1 individuals.
Results
Description of the sample of participants and clinics
Baseline characteristics of the 915 patients and 65 clinics
are shown in Table 2. People meeting the criteria for
MDE in the past year were mostly female (75%), married
or living common-law (51%) and 45% had completed a
high school education. The majority (78%) had at least
one chronic medical condition with 35% having three or
Table 1 Quality of treatment for depression according to different indicators based on patients’ self-reported data in
the Dialogue Project in 2008
Quality indicator Patients (n) Observed% (n) Indicator description
Detection of depression 915 68.1% (623) In the past 12 months, the respondent was told s/he
was suffering from depression OR received an
antidepressant prescription
Use of services
Use of services for mental health reason 915 86.2% (789) At least one consultation for mental health reason in
the past 12 months (family doctor/ general practitioner,
psychiatrist, other physicians, psychologist, nurse, social




137 40.1% (55) 3 or more medical consultation for mental health
reason in the past year (among untreated respondents,
i.e. respondents with at least one consultation for mental
health reason in the past 12 months but no
antidepressant prescription and no help in the form of
psychotherapy or counseling)
Psychotherapy
Any form of psychotherapy
or counseling
789 56.1% (443) Help in the form of psychotherapy or counseling in the
past 12 months (among those with at least one
consultation for mental health reason)
Adequate length session for
psychotherapy or counseling
443 88.9% (394) At least one session lasting 15 minutes or more of
psychotherapy or counseling with one or other of the
professionals consulted (among those who received
help in the form of psychotherapy or counseling)
At least one of the recommended
psychotherapy
394 83.2% (328) Cognitive behavior therapy AND/OR Interpersonal
therapy (among those who received at least one
session for counseling of adequate length)
Complete course of psychotherapy 443 60.7% (269) 12 or more consultations for mental health reason in
the past year. According to the Canadian
recommendations, a minimum of 12 visits is required
for a full course of psychotherapy (among those who
received help in the form of psychotherapy or counseling)
Adequate psychotherapy 443 49% (217) At least one of the recommended psychotherapy +
complete course of psychotherapy (among those who
received help in the form of psychotherapy or counseling)
Medication
Antidepressant prescription in the past year 915 59.5% (544) In the past 12 months, the respondent received an
antidepressant prescription
Adequate follow-up of the
prescription
544 77.9% (424) The respondent consulted 3 times or more the
professional who prescribed the medication(among
those who received an anti-depressant prescription)
Compliance support 544 80.1% (436) Any one or other of the professionals who prescribed
the medication helped the respondent follow the
course of treatment (among those who received an
anti-depressant prescription)
Patient education about antidepressant
prescription
Any one or other of the professionals who prescribed
the medication provided information on the subject
of. . . (among those who received an anti-depressant
prescription)
The effectiveness of treatment 544 72.8% (396)
The possible side effects 544 74.8% (407)
The probable length of treatment 544 59.2% (322)
Side effects you may expect to experience if you
stop taking the medication of your own accord
544 61.6% (335)
Adequate length of treatment 83 59% (49) The respondent have been taking the antidepressant
medication for 180 days or more (among those who
stopped their treatment)
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Table 1 Quality of treatment for depression according to different indicators based on patients’ self-reported data in
the Dialogue Project in 2008 (Continued)
Adequate dosage of antidepressant medication 458 88.9% (407) The respondent received at least one antidepressant
prescription at the minimum recommended dosage
(among those taking antidepressant medication at
the time of interview)
At least one minimally adequate treatment 789 60.5% (477) Adequate psychotherapy AND / OR
Antidepressant prescription in the past year with
adequate follow-up (≥ 3 times) (among those
with at least one consultation for mental health
reason or among the entire sample)
915 52.2% (477)
Patient education - information
General patient education -information 789 62.5% (493) In the past 12 months, the respondent received information
about mental health problems, existing treatments or
available services (among those with at least one
consultation for mental health reason)
Specific patient education - information The respondent received information about . . .
(among those who received general education – information)
Anxiety 493 72.8% (359)
Depression 493 83.6% (412)
Medication 493 78.7% (388)
Psychotherapy 493 55.6% (274)
Support and self-help groups in your area 493 39.8% (196)
Information sources such as books and Internet sites 493 50.3% (248)
Consideration of patient’s preferences 493 47.1% (232) The respondent received information about
medication AND psychotherapy
Advice or encouragement to do physical exercise 789 74.7% (589) With any one of the professionals, the respondent received
advice or encouragement to do physical exercise to improve
well-being, emotions and mental health (among those with
at least one consultation for mental health reason)
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teria for an episode of anxiety disorder in the past year.
For 70% of the sample, the first symptoms of depression
appeared more than 5 years ago. This implies that many
of these patients could be characterized as complex
cases. These characteristics also confirm that patients
were not all recruited at the same stage of their MDE.
Indeed, the average score on the HADS-D was less than
the cut-point of 8 that would indicate a possible depres-
sion and for 25% of the sample, the MDE occurred more
than 6 months ago.
The 65 clinics retained for this study included 21 com-
munity clinics (public funded clinics characterized by a
multidisciplinary and collaborative practice), 14 family
medicine groups (groups of physicians who work closely
with nurses, in an environment that promotes the prac-
tice of family medicine to registered individuals), 9 large
private clinics (6 GPs and more), 13 small private clinics
(2 to 5 GPs), and 8 “solo” clinics (one GP). Large and
small private clinics and solo clinics are characterized by
a variable mix of walk-in and family practice in a private
context. We found that for a large proportion of the
clinics, the inadequate mode of remuneration and the
lack of time for follow-up were significant barriers. In32% of clinics, all or most of the GPs used treatment
algorithms for the treatment of MDE or anxiety disor-
ders. For 62% of the clinics, psychotherapy was available
on-site and that may be explained by a large proportion
of clinics being community clinics or large family medi-
cine groups.Prevalence of minimally adequate treatment according to
quality indicators
In our sample of primary care adults meeting the criteria
for MDE in the past 12 months, 68% were detected, 86%
had a consultation for mental health reasons, 49% of
those treated by psychotherapy received adequate psy-
chotherapy, and 78% of those treated by ATD medica-
tion received adequate follow-up (Table 1). Overall,
28.5% received minimally adequate pharmacotherapy
only, 6.7% received minimally adequate psychotherapy
only, and 17% received both (Figure 2). More than half
of the respondents received some information about
mental health problems, existing treatments or available
services (62.5%) and almost 75% received advice or en-
couragement to do physical exercise to improve well-
being, emotions, and mental health.
Table 2 Characteristics of respondents meeting DSM-IV
MDE criteria (n =915) and of clinics where they sought
care (n = 65) in the Dialogue Project in 2008
Characteristics of respondents
Predisposing factors









Married / living common-law 51%
Widowed / separated / divorced 22%
Single 28%
Enabling factors
Perception of Economic Situation
Poor or Very Poor 30%
Well off / meet basic needs 70%
Have a family physician
Yes 83%
No 17%




Severity of depressive symptoms
(HADS depression sub-scale (mean (sd))
7.7 (4.4)
At least one comorbid Anxiety Disorder(GAD, Agoraphobia, SP, PD)
Yes 55%
No 45%
Perceived Mental Health as
Poor or Moderate 43%
Good or Very Good or Excellent 57%
Depression Episode
in Previous 6 months 75%
Between 6 and 12 months ago 25%
First Occurrence of Symptoms
> 5 years 70%





3 or more 35%
Table 2 Characteristics of respondents meeting DSM-IV
MDE criteria (n =915) and of clinics where they sought





Presence of a case manager for patients
suffering from anxiety or depressive disorders
Yes 46%
No 54%
Number of GP using treatment algorithms with
individuals suffering from anxiety or depressive disorders
None/Some 68%
All/Most 32%
Inadequate mode of remuneration to offer an “optimal level” of care
for patients suffering from anxiety or depressive disorders
Not at all / Slightly 14%
Fairly 31%
Highly 35%
Lack of time for follow-up to offer an “optimal level” of care for
patients suffering from anxiety or depressive disorders
Not at all / Slightly 14%
Fairly 46%
Highly 40%
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receiving at least one minimally adequate treatment
Findings showed non-significant between-clinic variation
in the likelihood of receiving at least one minimally ad-
equate treatment (level-2 variance component = 0.015;
p > 0.5).
The average probability of receiving at least one min-
imally adequate treatment was 52.1%. Computation of
the 95% plausible value range [43] indicated that this
probability varied between 46% and 58% across clinics.
However, since the variance component is notFigure 2 Receipt of minimally adequate treatment for
depression among a sample of 915 adults consulting in
primary care and meeting criteria for past year MDE in the
Dialogue Project in 2008.
Table 3 Factors associated with minimally adequate treatment for 915 respondents meeting DSM-IV MDE criteria
nested in 65 clinics in the Dialogue Project in 2008
Model with level 1 factors only Final model
Coefficient OR 95% CI Coefficient OR 95% CI
Individual characteristics
Intercept −0.72** 0.49 0.31 - 0.78 −1.34*** 0.26 0.14 - 0.48
Age
18-24 −0.43 0.65 0.4 - 1.05 −0.50* 0.61 0.37 - 0.99
25-44 (ref) - 1.00 - - 1.00 -
45-64 −0.18 0.83 0.61 - 1.13 −0.20 0.82 0.60 - 1.11
65+ −1.33*** 0.27 0.14 - 0.52 −1.45*** 0.23 0.12 - 0.47
Sex
Male −0.06 0.94 0.68 - 1.3 −0.13 0.88 0.63 - 1.22
Female (ref) - 1.00 - - 1.00 -
Has a family physician
Yes 0.47* 1.61 1.1 - 2.36 0.52** 1.68 1.14 - 2.48
No (ref) - 1.00 - - 1.00 -
Has a supplementary insurance coverage
Yes 0.55*** 1.73 1.3 - 2.3 0.53*** 1.70 1.27 - 2.27
No (ref) - 1.00 - - 1.00 -
At least one comorbid Anxiety Disorder
Yes 0.58*** 1.8 1.35 - 2.39 0.58*** 1.79 1.35 - 2.39
No (ref) - 1.00 - - 1.00 -
Severity of depressive symptoms
(HADS depression sub-scale)
0.07*** 1.07 1.04 - 1.11 0.07*** 1.07 1.04 - 1.11
Clinics characteristics
Psychotherapy available on-site
Yes 0.38* 1.46 1.06 - 2.02
No (ref) - 1.00 -
Number of GP using treatment algorithms with individuals suffering from anxiety or depressive disorders
All/Most 0.40* 1.49 1.07 - 2.08
None/Some (ref) - 1.00 -
Inadequate mode of remuneration to offer an “optimal level” of care for patients suffering from anxiety or depressive disorders
Not at all / Slightly 0.46* 1.58 1.07 - 2.35
Fairly 0.29 1.33 0.91 - 1.95
Highly (ref) - 1.00 -
* p < 0.05 **p < 0.01 ***p < 0.001.
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reflects sampling variance and not differences between
the clinics due to a real difference in quality.
Individual and clinic characteristics associated with the
likelihood of receiving at least one minimally adequate
treatment
Table 3 presents results regarding the association of pa-
tient predisposing characteristics, enabling resources,
and need factors as well as clinic characteristics and the
receipt of at least one minimally adequate treatment.Predisposing factors included only age: compared to
middle age people, younger (OR= 0.61; 95% CI [0.37 -
0.99]) and older people (OR=0.23; 95% CI [0.12 -
0.47]) were significantly less likely to receive adequate
treatment for depression. Among the enabling factors,
having a family physician (OR= 1.68; 95% CI [1.14 -
2.48]) and having a supplementary insurance coverage
(OR= 1.70; 95% CI [1.27 - 2.27]) were both associated
with more adequate treatment, as well as two need fac-
tors: severity of depressive symptoms (OR= 1.07; 95%
CI [1.04 - 1.11]) and suffering from at least one
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2.39]).
There were no significant differences between the
model with only level 1 factors and the full model, indi-
cating that level 2 variable effects are independent from
level 1 variables effects. Three clinic characteristics were
associated with adequacy of treatment: psychotherapy
available on-site (OR= 1.46; 95% CI [1.06 - 2.02]); all or
most GPs using treatment algorithms with individuals
suffering from anxiety or depressive disorders (OR= 1.49;
95% CI [1.07 - 2.08]); and the mode of remuneration to
offer an “optimal level” of care for patients suffering from
anxiety or depressive disorders perceived as “not at all”
or “slightly” inadequate (OR= 1.58; 95% CI [1.07 - 2.35]).
The presence of a case manager for patients suffering
from anxiety or depressive disorders was not associated
with the adequacy of treatment as we define it. Neither
were the lack of time for follow-up or the type of clinic.
To illustrate the impact of clinics characteristics, we
predicted the likelihood of receiving at least one minim-
ally adequate treatment for three virtual patients as a
function of clinic characteristics using estimates from the
final multilevel analysis model (Figure 3). The first virtual
patient is a “standard” patient (i.e. in the reference cat-
egory for all level-1 variables). The second patient has a
low probability of receiving minimally adequate treat-
ment. For the third patient, this probability is high. WeFigure 3 Estimated probability of receipt of at least one minimally ad
year MDE across two virtual clinics in the Dialogue Project in 2008. Le
25 and 44, No family physician, No supplementary insurance coverage, No
Virtual patient 2 (“Low probability” Patient): •Male, Aged 65 or more, No
anxiety disorder, Grand mean minus 1 as score on the HADS scale. Virtual
and 44, Family physician, Supplementary insurance coverage, Comorbid an
clinic): No psychotherapy on-site, None or some GP using treatment algori
Mode of remuneration to offer an “optimal level” of care for patients suffer
inadequate. Virtual clinic B (“Best” clinic): Psychotherapy on-site, All or m
anxiety or depressive disorders, Mode of remuneration to offer an “optimal
disorders perceived as not at all or slightly inadequate.contrasted those three patients in two virtual clinics: vir-
tual clinic A which doesn’t have the attributes associated
with increased probability of receipt of minimally ad-
equate treatment according to the multilevel model
(i.e. in the reference category for all level-2 variables),
and virtual clinic B which has those attributes.
The probability of receiving at least one minimally ad-
equate treatment varies between 5.1% and 89.3% de-
pending on the virtual patient and the virtual clinic.
Whatever the characteristics of the patient, the increase
in probability of receipt of minimally adequate treatment
associated with clinic characteristics is substantial. This
probability is more than doubled for virtual patient 1
and multiplied by 3 for virtual patient 2, the "low prob-
ability" patient. Even patients with a high probability of
adequate treatment, as virtual patient 3, can benefit from
being treated in clinics with the most favorable charac-
teristics, with a probability of adequate care increased by
almost 20%.
Discussion
The first objective of this study was to estimate the pro-
portion of primary care patients meeting DSM-IV criteria
for MDE who receive adequate treatment as assessed by
indicators derived from clinical practice guidelines. The
rates reported for the 27 indicators, with many of them
reported for the first time for patient suffering fromequate treatment for 3 virtual patients meeting criteria for past
gend: Virtual patient 1 (“Standard” patient): •Female, Aged between
comorbid anxiety disorder, Grand mean score on the HADS scale.
family physician, No supplementary insurance coverage, No comorbid
patient 3 (“High probability” Patient): •Female, Aged between 25
xiety disorder, Score on the HADS scale = 15. Virtual clinic A (“Worst”
thms with individuals suffering from anxiety or depressive disorders,
ing from anxiety or depressive disorders perceived as highly
ost of GP using treatment algorithms with individuals suffering from
level” of care for patients suffering from anxiety or depressive
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mark for future studies or quality improvement programs.
The second objective was to examine the individual and
organizational characteristics associated with the receipt
of at least one minimally adequate treatment for depres-
sion. Two enabling variables were significantly associated
with the outcome indicating that difficulty of access to
uncovered care and to a family physician represents a bar-
rier to depression treatment quality. The fact that two
need factors are significantly associated with the outcome
suggests that people more in need receive more adequate
care. Finally, three clinic-level factors were significantly
associated with more adequate care, pointing important
target to services quality improvement for patient suffer-
ing from depression.
Prevalence of adequate treatment according to quality
indicators
Adherence to guidelines was high (>75%) for one third of
the quality indicators that were measured but was low
(<60%) for nearly half of the measures, pointing to specific
targets for quality improvement. For example, untreated
patient are monitored (“watchful waiting”) in only 40% of
cases, which is lower than previously reported [10].
Educating patients about depression and its treatment
is often promoted in practice guidelines and its evalu-
ation seems relevant. Just over 60% of respondents who
consulted for mental health reasons reported receiving
information about mental health problems, existing
treatments or available services. Although this propor-
tion is almost three times higher than previously
reported [44,45], there remains room for improvement.
In our sample, the proportion of patients who received
education regarding pharmacotherapy (on the topic of
side effects, the expected efficacy of medication, the con-
sequences of discontinuing treatment prematurely, etc.)
ranged between 59% and 75% and were lower than esti-
mates observed in the Netherlands by Smolders et al.
[46]. In their study, proportions ranged from 93% to
98%, but physician self-report data were used. Dickinson
et al. [33] observed significantly lower proportions for
this type of indicator (43%) when using data that were
self-reported by patients. This difference in prevalence
may demonstrate a difference in perception between the
education practitioners think they have provided and
that which patients feel they have received.
We didn’t find previous data on advice or encourage-
ment to do physical exercise to improve mental health
for this type of population. In our study, even if evidence
of the benefits of physical activity for MDE is recent [47-
49], we found a surprisingly high rate on this indicator:
physical activity was recommended to three quarters of
the sample.Some indicators of pharmacotherapy quality revealed
good results. As demonstrated in other studies [50-52],
dosage of ATD is often adequate. The follow-up recom-
mended is often described in the guidelines as this as-
pect of depression care is critical given its role in
preventing relapse and recurrence and ensuring patient
safety [3,21]. In our sample, we found a high proportion
of adequate follow-up after a prescription of ATD in the
past year. Even if this result is similar to those found by
Hepner et al.[10], indicators related to the intensity of
follow-up have often suggested poor performance on
this aspect of care [33,53,54]. However, shorter periods
(3 or 6 months) were considered in those studies to
complete the number of follow-up visit required.
This study is one of the first to provide detailed data
on psychotherapy quality [28]. At 56%, our result is simi-
lar with that reported by Olfson et al. [55] who showed
that 60% of depressed individuals that had had at least
one contact with the health system for their depression
had received psychotherapy over a period of 12 months.
Some studies found lower proportions, ranging from
18% to 28%, but those lower rates can be explained by a
period of interest of only 6-months [8,13,56] or the con-
sideration of a larger population of people suffering from
depression (not only service users) as denominator [57].
We found a higher proportion of patients receiving
the recommended types of psychotherapy among people
receiving psychotherapy than Hepner et al. [10] (83% vs
55%), but their indicator considered only cognitive-
behavioral therapy whereas we considered also interper-
sonal therapy as adequate.
The proportion of patients who received at least one
adequate treatment among those who received a con-
sultation for mental health reason (60.5%) is in the
higher range of earlier findings [28]. When comparing
rates of quality indicators for depression treatment, we
have to be cautious as we demonstrated earlier [7,28]
that there seems to be three main factors that lead to di-
vergent results between studies, namely the populations
studied, the indicators used, and the sources of data
used. However our results support the conclusion that a
significant proportion of persons suffering from depres-
sion do not receive treatment considered to be minim-
ally adequate. This finding is all the more alarming
considering that it is based on indicators defined using
minimal criteria for quality and as such the actual qual-
ity of care may be even lower.
Individual characteristics associated with the likelihood of
receiving at least one minimally adequate treatment
Identifying the factors associated with adequate treat-
ment is a key factor for the development of interven-
tions to improve mental health treatment for patients
suffering from a MDE.
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associated with treatment adequacy: younger and espe-
cially older people were less likely to receive adequate
care for depression. However, young adults and elderly
are less likely to use health services for mental health
reasons [59]. This can explain our finding, as our indica-
tor of minimally adequate treatment relies partly on a
minimal number of visits. In a study of primary care
patients with anxiety or depression, Prins et al. [60]
showed that the individuals in the 18–24 years group are
significantly more likely to perceive a need for mental
health care, especially for information about mental ill-
ness, its treatment and available services compared to
the older age groups. The observation that young adults
would like to receive more information but are less likely
to receive adequate care for depression suggests that this
group should be prioritized in efforts to improve the
quality of care.
In our multilevel model, two enabling variables were
significantly associated with a higher probability of re-
ceipt of adequate treatment for depression: having a
family physician and having supplementary insurance.
The province of Quebec has a universal health insurance
for all citizens to obtain medical services and hospital
care they need. However, access to a regular family doc-
tor remains a challenge in Quebec and only 73.2% (95%
CI [71.1% - 75.2%]) of the population has one [61]. In
our sample, this proportion was higher (83%), which can
be explained by the recruitment of respondents in the
waiting rooms of primary care clinics. However, the
results of this study suggest that improving access to
family physicians may increase the likelihood of receiv-
ing adequate treatment for depression and reinforce the
relevance of current efforts in this direction.
The literature suggests that the effect of insurance on
quality is inconsistent. Having a private health insurance
is a factor for adequacy of care found in several studies
[58,62,63]. On the contrary, other authors [7,57] showed
that those without private insurance for health care were
not less likely to receive adequate treatment for depres-
sion. In Quebec, private psychotherapy sessions are not
covered by the universal health insurance. The consider-
ation of psychotherapy in our indicator of minimally ad-
equate care may explain why having supplementary
insurance is associated with adequate care.
On a positive note, it is reassuring to note that the
other predisposing factors (sex, education, and marital
status) and perceived poverty are not associated with the
receipt of adequate treatment for depression.
The fact that two evaluated need factors, severity of
depressive symptoms and comorbid anxiety disorder,
were retained in the multilevel model is encouraging:
people more in need are more likely to receive adequate
care. It is a well-known fact that anxiety and depressionare often co-occurring [64]. In our sample, more than
half of the respondents also had experienced at least one
comorbid anxiety disorder in the last year, which is asso-
ciated with adequacy of treatment for depression. Other
investigators [7,58,63,65] found the same association.
Young et al. [58] suggested that depressive symptoms
were easier to detect in people presenting both condi-
tions and that those requiring treatment for anxiety may
be more willing or have more opportunities to receive
treatment for their depressive disorder. In our study, we
evaluated need of care with objective clinical factors
only. Considering the patient’s perceived needs for care
could provide a different perspective, as individuals
meeting DSM-IV criteria for MDE do not necessarily
want help or believe they need therapy. Indeed, in a
similar study performed in the Netherlands, Prins et al.
[32] demonstrated that patients’ perceived needs for care
were more strongly associated with the delivery of
guideline-concordant care for anxiety and depression
than clinical need factors.
Clinic characteristics associated with the likelihood of
receiving at least one minimally adequate treatment
Three clinic-level factors were significantly associated
with more adequate care, pointing to important targets
for quality improvement in services for patient suffering
from depression.
Among the resources, psychotherapy on-site is a factor
related to adequate care for depression. The important
role of evidence-based psychotherapy in the treatment
of depression is underscored in many clinical guidelines
[3,21]. Richards et al. [66] showed that implementation
of evidence-based psychological therapies into routine
service settings are associated with improvement of de-
pressive symptoms. However access to those treatments
is still limited [67] and poor coordination with mental
health specialists can explain less than optimal depres-
sion care [45,68]. The ability to deliver psychotherapy on
site could improve the accessibility of psychotherapeutic
treatment and/or could make it easier to refer the pa-
tient to a professional that can deliver psychotherapy or
to engage in collaborative care. Indeed, it has been
shown in other circumstances that the actions of GPs
could be influenced by the resources available in an im-
mediate environment [69].
The use of treatment algorithms by all or most of the
GPs for patients with depression is also a factor asso-
ciated with adequate treatment at the clinic level. This is
consistent with the results of Wells et al. [8] who showed
that standardized treatment guidelines lead to better
quality of care, but also improved clinical outcome, men-
tal health– related functioning, and retention in employ-
ment of depressed patients. Use of treatment algorithms
can also be viewed as a reflect of GP knowledge to treat
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greater knowledge about treatment of depression were
more likely to care for patients with depression and to
deliver high-quality depression care [70,71].
It has been demonstrated that payment mechanisms
and financial incentives have significant effects on clin-
ical decision making [72,73]. It is therefore not surpris-
ing that this barrier is associated with the quality of the
treatment of depression in our study. Moreover, this is
consistent with the findings of Dickinson et al. [33] who
demonstrated that clinicians who provide more care for
chronic medical problems may have a practice style,
based on a model such as the chronic care model [74]
and mostly associated with payment by capitation, that
makes them more willing to provide greater depression
treatment intensity to their patients.
Henke et al. [45] underscored that even highly trained
and motivated clinicians will have difficulty providing
guideline-concordant depression practices without sup-
port from their clinic. Our results support this notion, as
we found both variables related to the clinicians know-
ledge (use of treatment algorithms) and related to the
clinic's organization (psychotherapy on-site and mode of
remuneration) associated with the quality of depression
treatment.
Limitations
The "Dialogue" Project provided high quality data on
common mental disorders and service utilization.
Nevertheless, results should be interpreted in light of
the characteristics of the present study, which was based
on self-reported cross sectional data.
Self-report data on the utilization of mental health ser-
vices are subject to social desirability and recall bias [75]
even though investigators reported acceptable concord-
ance between self-report and administrative data [76,77].
In this study, we were unable to assess the reliability of
the self-reported data, by a comparison with case notes
for example. However, efforts were made to help partici-
pants answering accurately. For example, for the medica-
tion dosage, participants were asked to get and read
their prescription or their pills box.
Temporality constitutes another limitation of cross-
sectional studies. Participants that were diagnosed shortly
before the administration of the survey may have just
begun treatment and may not have had enough time to
fulfill the consultation requirements. Likewise, services
may have been received by participants before the onset of
their depression.
Comorbidity with other mental health disorders is fre-
quent. Some indicators may include care received for
those comorbid conditions. Also, our definition of min-
imally adequate treatment did not consider the attitude
of patients, such as non-compliance to or refusal oftreatment; nor did it consider particular cases for which
deviating from the guidelines may have been appropriate.
Due to the sampling strategy, our sample may not rep-
resent the entire population of adults consulting a GP in
Quebec. The clinics response rate was less than 25%.
Generalization of the results of this study is therefore
limited.
Although our measure of minimally adequate treatment
has not been directly linked to outcomes, it is concordant
with guideline recommendations for high-quality depres-
sion treatment [19]. However, future research should focus
on the validation of these quality indicators, for instance
by studying their association with outcomes such as the
reduction in depressive symptoms.
Conclusions
This study enabled us to assess a large range of quality
indicators covering many important components of de-
pression treatment, and to examine the factors asso-
ciated with treatment adequacy in primary care at the
patient and the clinic levels. We found notable strengths
in the care received by the patients. However, we also
found important areas for quality improvement. As a
large proportion of depressed people receive treatment
only in primary care, the potential impact of targeting
those indicators in this sector is all the more relevant.
This study also highlights an important public health
problem: among patients reporting past-year MDE, only 1
out of 2 receive minimally adequate treatment. Our find-
ings suggest that interventions are needed to increase the
extent to which primary mental health care conforms to
evidence-based recommendations. These interventions
should target specific populations (i.e. the younger adults
and the elderly), enhance accessibility to psychotherapy
and to a regular family physician, and support primary
care physicians in their clinical practice with patients suf-
fering from depression in different ways such as develop-
ing knowledge to treat depression and adapting mode of
remuneration.
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